rtlmmldk | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/rtlmmldk_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/D%E2%80%99Alessio%2C_A.%3B_Del_Poggio%2C_P.%3B_Bracchi%2C_F.%3B_Cesana%2C_G.%3B_Sertori%2C_N.%3B_Di_Mauro%2C_D.%3B_Fargnoli%2C_A.%3B_Motta%2C_M.%3B_Giussani%2C_C.%3B_Moro%2C_P.%3B_Vitale%2C_G.%3B_Giacomini%2C_M.%3B_Borra%2C_G.>
?:doi	<https://research.tib.eu/covid-19/entity/10.1038/s41375-020-01087-z>
?:doi	10.1038/s41375-020-01087-z
?:journal	Leukemia
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/c441f20c7c7943a7d5788df15be0651368eef3f0.json
?:pmc_json_files	document_parses/pmc_json/PMC7654848.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7654848>
?:pmid	<https://research.tib.eu/covid-19/entity/33173161.0>
?:pmid	33173161.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/rtlmmldk_HAS_C0038317_TREATS_C0032285>
?:sha_id	<https://research.tib.eu/covid-19/entity/c441f20c7c7943a7d5788df15be0651368eef3f0>
?:source	Medline; PMC
?:title	Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-10

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/rtlmmldk>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/rtlmmldk>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all